| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/14/1997 | US5593858 Culturing host/vector pair where the host is selected from kluyveromyces |
| 01/14/1997 | US5593857 Production of homogeneous truncated CNTF |
| 01/14/1997 | US5593846 Methods for the detection of soluble β-amyloid peptide |
| 01/14/1997 | US5593844 Ligand-mediated immunofunctional hormone binding protein assay method |
| 01/14/1997 | US5593842 Method of measuring thymopoietin proteins in plasma and serum including acidification of the plasma and serum |
| 01/14/1997 | US5593833 Bone disorders |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593698 Immunosuppressants |
| 01/14/1997 | US5593669 Pesticide, insecticide |
| 01/14/1997 | US5593667 Recombinant immune interferon having an intact carboxyl terminus |
| 01/14/1997 | CA2088671C Use of canps-inhibitors in pharmaceutical preparations |
| 01/14/1997 | CA2020062C Antibiotic agent |
| 01/14/1997 | CA1338849C Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/14/1997 | CA1338848C Hydrogenated derivatives of antibiotic a/16686 |
| 01/09/1997 | WO1997000965A2 A lipidic vector for nucleic acid delivery |
| 01/09/1997 | WO1997000964A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 01/09/1997 | WO1997000963A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | WO1997000962A1 A novel method to isolate mutants and to clone the complementing gene |
| 01/09/1997 | WO1997000961A1 Plant regulatory proteins iii |
| 01/09/1997 | WO1997000960A1 Novel human chemotactic cytokine |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000958A1 NOVEL TGF-β LIKE CYTOKINE |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000956A1 Hypoxia-responsive adhesion molecules, specific antibodies, and their uses |
| 01/09/1997 | WO1997000955A1 Human homolog of the mouse rab18 gene |
| 01/09/1997 | WO1997000954A1 C-cam expression constructs and their application in cancer therapy |
| 01/09/1997 | WO1997000953A1 Aortic preferentially-expressed gene apeg-1 and uses thereof |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000951A1 Dna encoding porcine complement inhibitor |
| 01/09/1997 | WO1997000950A1 New immunoregulatory protein lst-1 |
| 01/09/1997 | WO1997000945A1 Recombinant sweet protein mabinlin |
| 01/09/1997 | WO1997000895A1 Crystals of fragments of cd40 ligand and their use |
| 01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | WO1997000893A1 Interleukin-8 receptor binding compounds |
| 01/09/1997 | WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | WO1997000890A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |
| 01/09/1997 | WO1997000886A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | WO1997000855A1 Herpes ribonucleotide reductase inhibitors |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1997000690A1 Interleukin-1 receptor-associated protein kinase and assays |
| 01/09/1997 | WO1997000601A2 Polypeptides with interleukin-8 receptor binding |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996039504A3 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein |
| 01/09/1997 | WO1996038560A3 Genetic control of flowering |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | WO1996036881A3 Screening for inhibitors of tcr-mhc interactions |
| 01/09/1997 | WO1996034088A3 Control of floral induction in plants and uses therefor |
| 01/09/1997 | WO1996032471A3 Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | DE19525924A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/09/1997 | DE19523279A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren mittels rekombinanter Mikroorganismen mit erhöhter Sekretionsrate Process for the microbial production of amino acids by recombinant microorganisms with increased secretion |
| 01/09/1997 | CA2226085A1 Aortic preferentially-expressed gene and uses thereof |
| 01/09/1997 | CA2225600A1 Gibberellin-regulated myb polypepetides |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225377A1 Novel tgf-.beta. like cytokine |
| 01/09/1997 | CA2225318A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | CA2224872A1 Dna encoding a porcine complement inhibitor |
| 01/09/1997 | CA2224867A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2224812A1 Crystals of fragments of cd40 ligand and their use |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | CA2224624A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | CA2224247A1 Human homolog of the mouse rab18 gene |
| 01/08/1997 | EP0752477A2 Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors |
| 01/08/1997 | EP0752475A1 Modified bacterial alkaline phosphatases and their uses |
| 01/08/1997 | EP0752474A1 Nucleic acid coding for CMP-N-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins |
| 01/08/1997 | EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains |
| 01/08/1997 | EP0752472A1 Novel gene originating in corynebacterium and use thereof |
| 01/08/1997 | EP0752426A2 Synthetic calibrators for use in immunoassays, consisting of analytes or parts thereof conjugated to inert carrier molecules |
| 01/08/1997 | EP0752425A2 Peptide ligands for the constant region of immunoglobulins |
| 01/08/1997 | EP0752103A1 Methods for detecting calpain activation and indentifying calpain inhibitors |
| 01/08/1997 | EP0752008A1 Dna mutagenesis by random fragmentation and reassembly |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752001A1 Biological insect control agent |
| 01/08/1997 | EP0751998A1 A gene expression system utilizing an rna polymerase prebound to dna |
| 01/08/1997 | EP0751994A1 C-terminally truncated cftr genes and proteins |
| 01/08/1997 | EP0751993A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751988A1 Highly efficient production and isolation of viral particles |
| 01/08/1997 | EP0751961A1 Eating suppressant peptides |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 01/08/1997 | EP0751959A1 Modified polypeptides with increased biological activity |
| 01/08/1997 | EP0751958A1 Flucose containing proteoglycan or acid glycan and their pharmaceutical use |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751956A1 $i(PASTEURELLACEAE) ANTIGENS AND RELATED VACCINES |
| 01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins |
| 01/08/1997 | EP0751953A1 Neuropeptides and their use as insecticides |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |